Overview

Study Of Generalized Anxiety Disorder

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy and safety in Generalized Anxiety Disorder patients
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Paroxetine